Takeaways From ACI’s State Regulators Roundtable on PFAS Regulation, Compliance and Litigation

June 5, 2025

Reading Time : 1 min

By: David H. Quigley, Shivani Swami (International Law Advisor)

On May 29, 2025, David Quigley (head of Akin’s Environment & Natural Resources Section) led a discussion among Katrina Kessler (Commissioner, Minnesota Pollution Control Agency), Susanne Miller (Bureau Director, Maine Department of Environmental Protection), Amy Rousseau (PFAS Response Coordinator, New Hampshire Department of Environmental Services) and Joaquin Esquivel (Board Chair, California State Water Resources Control Board) at a State Regulators Roundtable hosted by the American Conference Institute during its 2nd annual summit on per- and polyfluoroalkyl substances (PFAS) regulation, compliance and litigation. Key takeaways from the discussion included the following:

  • Minnesota will not consider a fluoropolymer-based exemption from its all-product ban and reporting regulations. Ms. Kessler views her state’s legislation as applying to all PFAS unless their use is deemed currently unavoidable. With respect to Minnesota’s reporting rule, Ms. Kessler indicated that her agency will make changes to address industry concerns raised during the just-concluded comment period, but that in the end she expects many of the issues concerning number and cost of reports to be resolved by joint submissions. She confirmed that each manufacturer need only pay one annual fee to cover all reports.
  • In New Hampshire, Ms. Rousseau indicated that much of the current conversation focuses on funding PFAS work, as a number of legislators asked for her assistance in developing a fee collection proposal, potentially based on Minnesota’s model described above. All of the state officials expressed concerns around the funding piece and advocated for increased federal-state coordination to finance PFAS management, particularly in light of expected federal reductions.
  • On the federal front – Travis Voyles, Assistant Deputy Administrator at the Environmental Protection Agency (EPA) (and interim lead for the cross-agency PFAS work group) noted at the summit that the Agency is still reviewing the designation of PFOA and PFOS as “hazardous substances” under Superfund and announced the administration’s intention to get away from a statute-by-statute approach in favor of a greater overarching policy. Mr. Voyles indicated that the Agency soon would appoint a new “PFAS leader” to succeed him in his interim role.

Share This Insight

Previous Entries

PFAS Press

November 11, 2025

On November 10, 2025, the U.S. Environmental Protection Agency (EPA) released the pre-publication draft proposed rule to amend the PFAS reporting requirements under TSCA, entitled “Perfluoroalkyl and Polyfluoroalkyl Substances (PFAS) Data Reporting and Recordkeeping Under the Toxic Substances Control Act (TSCA); Revision to Regulation.” The proposal aims to augment the exemptions to the scope of the reporting requirements and introduces additional modifications to make the rule “more practical and implementable and reduce unnecessary, or potentially duplicative, reporting requirements for businesses.” Potentially offering even greater flexibility, it concludes with a request for comment on additional provisions. 

...

Read More

PFAS Press

September 16, 2025

On September 4, the U.S. Environmental Protection Agency (EPA) (finally) published its Spring 2025 Unified Agenda of Regulatory and Deregulatory Actions (UA), a semiannual publication outlining federal agencies’ regulatory priorities and timelines for the upcoming year. The UA included a notice of its intent to rescind drinking water limits set by a Biden-era rule for three per- and polyfluoroalkyl (PFAS) substances and one PFAS mixture. EPA also published a notice of intent to retain limits on PFOA and PFOS, although with extended timelines for compliance.

...

Read More

PFAS Press

September 5,2025

On August 20, 2025, Denmark, Germany, the Netherlands, Norway and Sweden submitted an update to the proposal to restrict PFAS under the European Union’s REACH regulation that they originally submitted in January 2023. The revision reflects their comprehensive evaluation of more than 5,000 scientific and technical comments submitted by stakeholders, including industry representatives, researchers and civil society organizations.

...

Read More

PFAS Press

August 6, 2025

On August 6, 2025, the U.S. Food and Drug Administration (FDA) became the latest governmental agency to confirm that fluoropolymers are both safe and necessary. After an independent safety review of fluoropolymers in medical devices showed no conclusive evidence of health issues, FDA concluded that fluoropolymers are “very unlikely to cause toxicity” because of molecular size and further that they are essential for medical devices to function. As a result, “FDA’s evaluation is that currently there is no reason to restrict their continued use in devices.”

...

Read More

© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.